Levels of renin, angiotensin I and II, angiotensin-converting enzyme and aldosterone in infancy and childhood. 1983

T J Fiselier, and P Lijnen, and L Monnens, and P van Munster, and M Jansen, and P Peer

Basal plasma renin activity (PRA), angiotensin I and II (AI, AII), angiotensin-converting enzyme (ACE) activity and plasma aldosterone (PA) and sodium and potassium concentration were simultaneously measured in 55 healthy recumbent children aged between 1 week and 13 years. A significant (P less than 0.001) age-related decrease for PRA (r = -0.73), AI (r = -0.72), AII (r = -0.51) and PA (r = -0.71) was observed but not for ACE (r = 0.26, P = 0.06). After correction for age the correlation between PRA or PA and AI or AII was still significant (P less than 0.005). The strong correlation between AI and AII in the group as a whole (r = 0.82, P less than 0.001) and also in separate age groups, and an AI to AII ratio which was not different between the various age groups suggest that ACE activity in this age range is not rate-limiting for AII generation.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007703 Peptidyl-Dipeptidase A A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020). ACE1 Angiotensin-Converting Enzyme 1,ACE1 Protein,Angiotensin Converting Enzyme,Angiotensin Converting Enzyme 1,Antigens, CD143,CD143 Antigens,Dipeptidyl Carboxypeptidase I,Kininase II,Peptidase P,Angiotensin I-Converting Enzyme,Carboxycathepsin,Dipeptidyl Peptidase A,Kininase A,ACE1 Angiotensin Converting Enzyme 1,Angiotensin I Converting Enzyme,Carboxypeptidase I, Dipeptidyl,Peptidyl Dipeptidase A
D008297 Male Males
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females

Related Publications

T J Fiselier, and P Lijnen, and L Monnens, and P van Munster, and M Jansen, and P Peer
January 1985, Nihon Jinzo Gakkai shi,
T J Fiselier, and P Lijnen, and L Monnens, and P van Munster, and M Jansen, and P Peer
January 1993, Nephron,
T J Fiselier, and P Lijnen, and L Monnens, and P van Munster, and M Jansen, and P Peer
April 2021, ESC heart failure,
T J Fiselier, and P Lijnen, and L Monnens, and P van Munster, and M Jansen, and P Peer
January 2020, Frontiers in pharmacology,
T J Fiselier, and P Lijnen, and L Monnens, and P van Munster, and M Jansen, and P Peer
April 2005, Acta diabetologica,
T J Fiselier, and P Lijnen, and L Monnens, and P van Munster, and M Jansen, and P Peer
September 1983, Journal of applied physiology: respiratory, environmental and exercise physiology,
T J Fiselier, and P Lijnen, and L Monnens, and P van Munster, and M Jansen, and P Peer
January 1987, Agents and actions. Supplements,
T J Fiselier, and P Lijnen, and L Monnens, and P van Munster, and M Jansen, and P Peer
January 2014, PloS one,
T J Fiselier, and P Lijnen, and L Monnens, and P van Munster, and M Jansen, and P Peer
October 1983, Journal of applied physiology: respiratory, environmental and exercise physiology,
T J Fiselier, and P Lijnen, and L Monnens, and P van Munster, and M Jansen, and P Peer
March 2020, Journal of veterinary internal medicine,
Copied contents to your clipboard!